Taro Pharm Inds (TARO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2018 | 03-2017 | 03-2016 | 03-2015 | 03-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 576,611 | 600,399 | 576,757 | 481,840 | 209,960 |
| Marketable Securities | 846,009 | 786,361 | 651,869 | 438,357 | 3,250 |
| Receivables | 329,420 | 470,204 | 509,335 | 473,338 | 138,770 |
| Inventories | 144,595 | 141,045 | 138,553 | 120,272 | 117,630 |
| Other current assets | 0 | 1,015 | 1,081 | 0 | 581,660 |
| TOTAL | $1,896,635 | $1,999,024 | $1,877,595 | $1,513,807 | $1,051,270 |
| Non-Current Assets | |||||
| PPE Net | 193,727 | 180,085 | 159,459 | 153,045 | 151,410 |
| Investments And Advances | 225,639 | 70,685 | 115,173 | 30,175 | 0 |
| Other Non-Current Assets | 117,209 | 39,959 | 35,806 | 40,718 | 81,680 |
| TOTAL | $536,575 | $290,729 | $310,438 | $223,938 | $233,090 |
| Total Assets | $2,433,210 | $2,289,753 | $2,188,033 | $1,737,745 | $1,284,370 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | N/A | 912 | 11,970 |
| Accounts payable and accrued liabilities | 25,697 | 16,394 | 18,853 | 19,480 | 241,330 |
| Other current liabilities | 190,059 | 193,443 | 226,609 | 289,613 | 0 |
| TOTAL | $215,756 | $209,837 | $245,462 | $310,005 | $253,300 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 4,976 | 5,880 |
| Other Non-Current Liabilities | 4,898 | 3,686 | 2,856 | 2,903 | 2,378 |
| TOTAL | $7,055 | $6,110 | $5,427 | $10,357 | $10,460 |
| Total Liabilities | $222,811 | $215,947 | $250,889 | $320,362 | $263,780 |
| Shareholders' Equity | |||||
| Common Shares | 679 | 679 | 679 | 679 | 670 |
| Retained earnings | 2,662,327 | 2,451,177 | 1,994,821 | 1,453,889 | 969,630 |
| Other shareholders' equity | -105,052 | -141,495 | -116,801 | -105,630 | -18,120 |
| TOTAL | $2,210,399 | $2,073,806 | $1,937,144 | $1,417,383 | $1,020,590 |
| Total Liabilities And Equity | $2,433,210 | $2,289,753 | $2,188,033 | $1,737,745 | $1,284,370 |